Atomera Inc. Files Definitive Proxy for Shareholder Vote to Double Authorized Common Stock, Enabling Significant Future Dilution

summarizeSummary

Atomera Inc. filed its definitive proxy, seeking shareholder approval to double authorized common stock to 95 million, which could lead to over 145% dilution. This is a critical step for future financing given the company's ongoing losses.

check_boxKey Events

• Shareholders to Vote on Doubling Authorized Common Stock

  The company proposes to increase authorized common stock from 47.5 million to 95 million shares. With 38.7 million shares currently outstanding, this would create headroom for an additional 56.3 million shares, representing a potential dilution of approximately 145% if all authorized shares were issued. This definitive filing follows a preliminary proxy statement on March 17, 2026, which first disclosed this proposal.

• Auditor Ratification Follows Resignation

  Shareholders will vote to ratify the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for 2026. This follows the resignation of Marcum LLP on March 18, 2025, with no reported disagreements or reportable events.

• Executive Compensation Adjusted for Performance

  For 2025, cash bonus payouts to NEOs were reduced by 50% and to the CEO by 100% due to customer setbacks. New performance-based stock options (PSOs) were granted in March 2026, with vesting tied to achieving stock price hurdles of $7.50, $12.50, and $20.00, aiming to align executive incentives with long-term shareholder value.

auto_awesomeAnalysis

Atomera Inc. has filed its definitive proxy statement, setting the stage for a critical shareholder vote on May 12, 2026, to significantly increase its authorized common stock. The proposal seeks to nearly double the authorized shares from 47.5 million to 95 million. Given the current outstanding shares of 38.7 million, this authorization would create headroom for an additional 56.3 million shares, representing a potential dilution of approximately 145% if all authorized shares were issued. This move is crucial for the company, which reported a $20.2 million net loss in 2025 and minimal revenue, as it provides flexibility for future capital raises, equity compensation, and strategic transactions. While necessary for long-term financial runway, the substantial potential dilution could weigh on investor sentiment. Additionally, the filing ratifies the appointment of CBIZ CPAs P.C. as the independent auditor, following Marcum LLP's resignation in March 2025, with no reported disagreements. Executive compensation for 2025 reflects a response to customer setbacks, with reduced cash bonuses and new performance-based stock options tied to significant stock price appreciation, aiming to align management incentives with shareholder value.